Avidity Biosciences jumps on report of Novartis takeover approach

18 hours ago 2

• On the Move

• Comments

Tamer Soliman

Avidity Bioscienes (NASDAQ:RNA) quickly soared 20% after a report that Novartis (NYSE:NVS) made a takeover approach for the rare-disease maker. Novartis (NYSE:NVS) has expressed its interest in Avidity (NASDAQ:RNA) in recent weeks, according to

Recommended For You

More Trending News

See More »

1. Homepage
2. Politics
3. Avidity Biosciences jumps on report of Novartis takeover approach